Full Text
Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma

Abstract

Authors

J Kim JW Hay

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×